Samsara BioCapital’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,244
| Closed | -$158K | – | 44 |
|
|
2023
Q2 | $158K | Hold |
21,244
| – | – | 0.03% | 44 |
|
|
2023
Q1 | $147K | Hold |
21,244
| – | – | 0.03% | 52 |
|
|
2022
Q4 | $218K | Hold |
21,244
| – | – | 0.05% | 49 |
|
|
2022
Q3 | $387K | Hold |
21,244
| – | – | 0.09% | 49 |
|
|
2022
Q2 | $1.09M | Sell |
21,244
-5,900
| -22% | -$304K | 0.29% | 43 |
|
|
2022
Q1 | $2M | Hold |
27,144
| – | – | 0.5% | 40 |
|
|
2021
Q4 | $3.88M | Sell |
27,144
-3,016
| -10% | -$431K | 0.75% | 25 |
|
|
2021
Q3 | $6.25M | Hold |
30,160
| – | – | 0.98% | 22 |
|
|
2021
Q2 | $6.4M | Hold |
30,160
| – | – | 0.79% | 22 |
|
|
2021
Q1 | $5.47M | Hold |
30,160
| – | – | 1.01% | 21 |
|
|
2020
Q4 | $3.36K | Buy |
30,160
+8,500
| +39% | +$948 | 0.34% | 28 |
|
|
2020
Q3 | $2.35M | Buy |
+21,660
| New | +$2.35M | 0.65% | 25 |
|